DaVita Inc. to Participate in the Barclays Global Healthcare Conference 2025
PRNewswire (Thu, 6-Mar 10:00 AM ET)
Globe Newswire (Thu, 27-Feb 9:00 AM ET)
DaVita Inc. 4th Quarter 2024 Results
PRNewswire (Thu, 13-Feb 4:05 PM ET)
DaVita Inc. Schedules 4th Quarter 2024 Investor Conference Call
PRNewswire (Thu, 30-Jan 11:56 AM ET)
DaVita Celebrates 25 Years of Exceptional Patient Care, Empowering the Future of Kidney Health
PRNewswire (Wed, 15-Jan 9:05 AM ET)
DaVita Supports Thousands of Patients and Teammates Affected by Southern California Wildfires
PRNewswire (Thu, 9-Jan 11:00 AM ET)
Is DVA stock going up before upcoming earnings? Let's turn to history for clues
Market Chameleon (Thu, 8-Feb 6:05 AM ET)
A Stock Rise in DVA has History on Its Side
Market Chameleon (Wed, 7-Feb 5:19 AM ET)
DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. Berkshire Hathaway owns about 45% of DaVita.
Davita trades on the NYSE stock market under the symbol DVA.
As of April 9, 2025, DVA stock price climbed to $145.02 with 240,188 million shares trading.
DVA has a beta of 0.61, meaning it tends to be less sensitive to market movements. DVA has a correlation of 0.12 to the broad based SPY ETF.
DVA has a market cap of $11.60 billion. This is considered a Large Cap stock.
Last quarter Davita reported $3 billion in Revenue and $2.24 earnings per share. This beat revenue expectation by $29 million and exceeded earnings estimates by $.10.
In the last 3 years, DVA traded as high as $179.60 and as low as $65.28.
The top ETF exchange traded funds that DVA belongs to (by Net Assets): VTI, VOO, VB, RSP, VBR.
DVA has outperformed the market in the last year with a price return of +8.4% while the SPY ETF lost -2.8%. DVA has also outperformed the stock market ETF in the last 3 month and 2 week periods returning -5.8% and -3.8%, respectively, while the SPY returned -15.4% and -13.7%, respectively.
DVA support price is $140.94 and resistance is $146.90 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that DVA shares will trade within this expected range on the day.